Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor

被引:5
|
作者
Burmeister, M. A. [1 ]
Bracy, D. P. [2 ]
James, F. D. [2 ]
Holt, R. M. [1 ]
Ayala, J. [1 ]
King, E. M. [3 ]
Wasserman, D. H. [2 ]
Drucker, D. J. [4 ]
Ayala, J. E. [1 ,3 ]
机构
[1] Sanford Burnham Med Res Inst Lake Nona, Diabet & Obes Res Ctr, Metab Signaling & Dis Program, Orlando, FL 32827 USA
[2] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[3] Sanford Burnham Med Res Inst Lake Nona, Cardiometab Phenotyping Core, Orlando, FL 32827 USA
[4] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2012年 / 590卷 / 20期
基金
美国国家卫生研究院;
关键词
INSULIN-SECRETION; GLP-1; RECEPTORS; ENERGY-BALANCE; INCRETIN; METABOLISM; MICE; SUPPRESSION; SENSITIVITY; MUSCLE; AMIDE;
D O I
10.1113/jphysiol.2012.234914
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Key points Glucagon-like peptide-1 (Glp1) regulates hepatic glucose production (HGP) and muscle glucose uptake (MGU) via its ability to stimulate insulin secretion. Using exercise as a means to stimulate glucose flux independently of insulin secretion, we observed that Glp1 receptor (Glp1r) knockout (Glp1r-/-) mice become hyperglycaemic but display normal rates of MGU. Since euglycaemia during exercise is typically maintained by matching rates of HGP to rates of MGU, we hypothesize that exercise-induced hyperglycaemia in Glp1r-/- mice is due to excessive HGP. Using innovative catheterization and isotope dilution techniques, we demonstrate that hyperglycaemia in exercising Glp1r-/- mice is associated with excessive HGP and glucagon secretion. These results suggest an essential and novel role for basal Glp1r signalling in the suppression of alpha cell secretion during exercise. Abstract In response to oral glucose, glucagon-like peptide-1 receptor (Glp1r) knockout (Glp1r-/-) mice become hyperglycaemic due to impaired insulin secretion. Exercise also induces hyperglycaemia in Glp1r-/- mice. In contrast to oral glucose, exercise decreases insulin secretion. This implies that exercise-induced hyperglycaemia in Glp1r-/- mice results from the loss of a non-insulinotropic effect mediated by the Glp1r. Muscle glucose uptake (MGU) is normal in exercising Glp1r-/- mice. Thus, we hypothesize that exercise-induced hyperglycaemia in Glp1r-/- mice is due to excessive hepatic glucose production (HGP). Wild-type (Glp1r+/+) and Glp1r-/- mice implanted with venous and arterial catheters underwent treadmill exercise or remained sedentary for 30 min. [3-3H]glucose was used to estimate rates of glucose appearance (Ra), an index of HGP, and disappearance (Rd). 2[14C]deoxyglucose was used to assess MGU. Glp1r-/- mice displayed exercise-induced hyperglycaemia due to an excessive increase in Ra but normal Rd and MGU. Exercise-induced glucagon levels were 2-fold higher in Glp1r-/- mice, resulting in a 2-fold higher glucagon:insulin ratio. Since inhibition of the central Glp1r stimulates HGP, we tested whether intracerebroventricular (ICV) infusion of the Glp1r antagonist exendin(939) (Ex9) in Glp1r+/+ mice would result in exercise-induced hyperglycaemia. ICV Ex9 did not enhance glucose levels or HGP during exercise, suggesting that glucoregulatory effects of Glp1 during exercise are mediated via the pancreatic Glp1r. In conclusion, functional disruption of the Glp1r results in exercise-induced hyperglycaemia associated with an excessive increase in glucagon secretion and HGP. These results suggest an essential role for basal Glp1r signalling in the suppression of alpha cell secretion during exercise.
引用
收藏
页码:5245 / 5255
页数:11
相关论文
共 50 条
  • [21] Is there a role for glucagon-like peptide-1 receptor agonists in the treatment of male infertility?
    Cannarella, Rossella
    Calogero, Aldo E.
    Condorelli, Rosita A.
    Greco, Emanuela A.
    Aversa, Antonio
    La Vignera, Sandro
    ANDROLOGY, 2021, 9 (05) : 1499 - 1503
  • [22] Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor
    Bird, Gregory H.
    Fu, Accalia
    Escudero, Silvia
    Godes, Marina
    Opoku-Nsiah, Kwadwo
    Wales, Thomas E.
    Cameron, Michael D.
    Engen, John R.
    Danial, Nika N.
    Walensky, Loren D.
    ACS CHEMICAL BIOLOGY, 2020, 15 (06) : 1340 - 1348
  • [23] A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
    Zhao, Li
    Chen, Yi
    Xia, Fangzhen
    Abudukerimu, Buatikamu
    Zhang, Wen
    Guo, Yuyu
    Wang, Ningjian
    Lu, Yingli
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [24] Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited
    Hansen, Jan
    Brock, Birgitte
    Botker, Hans Erik
    Gjedde, Albert
    Rungby, Jorgen
    Gejl, Michael
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2014, 15 (03) : 219 - 231
  • [25] Why is it so difficult to measure glucagon-like peptide-1 in a mouse?
    Windelov, Johanne A.
    Albrechtsen, Nicolai J. Wewer
    Kuhre, Rune E.
    Jepsen, Sara L.
    Hornburg, Daniel
    Pedersen, Jens
    Jensen, Elisa P.
    Galsgaard, Katrine D.
    Winther-Sorensen, Marie
    Orgaard, Anne
    Deacon, Carolyn F.
    Mann, Matthias
    Kissow, Hannelouise
    Hartmann, Bolette
    Holst, Jens J.
    DIABETOLOGIA, 2017, 60 (10) : 2066 - 2075
  • [26] The physiological role of glucagon-like peptide-1 in the regulation of renal function
    Farah, Livia X. S.
    Valentini, Vanessa
    Pessoa, Thaissa D.
    Malnic, Gerhard
    McDonough, Alicia A.
    Girardi, Adriana C. C.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (02) : F123 - F127
  • [27] Glucagon-Like Peptide-1 Receptor Agonist and Glucagon Increase Glucose-Stimulated Insulin Secretion in Beta Cells via Distinct Adenylyl Cyclases
    Lee, Young-Sun
    Jun, Hee-Sook
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2018, 15 (06): : 603 - 609
  • [28] β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy
    Garibay, Darline
    McGavigan, Anne K.
    Lee, Seon A.
    Ficorilli, James V.
    Cox, Amy L.
    Michael, M. Dodson
    Sloop, Kyle W.
    Cummings, Bethany P.
    ENDOCRINOLOGY, 2016, 157 (09) : 3405 - 3409
  • [29] Glucagon-Like Peptide-1 Gene Therapy
    Rowzee, Anne M.
    Cawley, Niamh X.
    Chiorini, John A.
    Di Pasquale, Giovanni
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [30] Impaired brain glucose metabolism in glucagon-like peptide-1 receptor knockout mice
    Li, Hui
    Fang, Yujiao
    Wang, Da
    Shi, Bowen
    Thompson, Garth J.
    NUTRITION & DIABETES, 2024, 14 (01):